Genetic Causes of Focal Segmental Glomerulosclerosis & Patient Selection

Dr. Ladan Zand, an Associate Professor of Medicine in Nephrology at Mayo Clinic in Rochester, MN, shares results of her study appearing in the September 2021 issue of Mayo Clinic Proceedings where she and her colleagues were able to identify 4 groups of patients with focal segmental glomerulosclerosis: 1) Primary FSGS; 2) Secondary FSGS with known cause; 3) Secondary FSGS with unknown cause; and 4) undetermined FSGS. Dr. Zand notes these classifications are important for determining the best treatment options for each type. Available at: mayocl.in/3j18TI9